Fair Value Measurements (Changes In Level 3 Assets And (Liabilities) Measured At Fair Value On A Recurring Basis) (Detail) (USD $)
In Millions, unless otherwise specified |
3 Months Ended | 9 Months Ended | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2014
|
Sep. 30, 2013
|
Sep. 30, 2014
|
Sep. 30, 2013
|
|||||||||||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||||||||||||
Settlements | $ (4) | $ (1) | $ 54 | $ 9 | ||||||||||||
Power [Member]
|
||||||||||||||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||||||||||||
Gains and losses attributable to changes in net derivative assets and liabilities, included in Operating Income | (8) | 1 | (66) | (16) | ||||||||||||
Gains and losses attributable to changes in net derivative assets and liabilities, unrealized | (12) | 1 | (11) | (7) | ||||||||||||
Net Derivative Assets (Liabilities) [Member]
|
||||||||||||||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||||||||||||
Opening Balance | 13 | (35) | 88 | (31) | ||||||||||||
Included in Income | (8) | [1] | 1 | [1] | (66) | [1] | (16) | [1] | ||||||||
Included in Regulatory Assets/Liabilities | (9) | [2] | (11) | [2] | (81) | [2] | (12) | [2] | ||||||||
Purchases, (Sales) | 0 | 0 | 0 | 0 | ||||||||||||
Issuances (Settlements) | (4) | [3] | (1) | [3] | 54 | [3] | 9 | [3] | ||||||||
Transfers In (Out) | 0 | [4] | 0 | [4] | (3) | [4] | 4 | [4] | ||||||||
Closing Balance | (8) | (46) | (8) | (46) | ||||||||||||
Net Derivative Assets (Liabilities) [Member] | Power [Member]
|
||||||||||||||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||||||||||||
Opening Balance | (9) | 6 | (6) | 9 | ||||||||||||
Included in Income | (8) | [1] | 1 | [1] | (66) | [1] | (16) | [1] | ||||||||
Included in Regulatory Assets/Liabilities | 0 | [2] | 0 | [2] | 0 | [2] | 0 | [2] | ||||||||
Purchases, (Sales) | 0 | 0 | 0 | 0 | ||||||||||||
Issuances (Settlements) | (4) | [3] | (1) | [3] | 54 | [3] | 9 | [3] | ||||||||
Transfers In (Out) | 0 | [4] | 0 | [4] | (3) | [4] | 4 | [4] | ||||||||
Closing Balance | (21) | 6 | (21) | 6 | ||||||||||||
Net Derivative Assets (Liabilities) [Member] | PSE And G [Member]
|
||||||||||||||||
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||||||||||||
Opening Balance | 22 | (41) | 94 | (40) | ||||||||||||
Included in Income | 0 | [1] | 0 | [1] | 0 | [1] | 0 | [1] | ||||||||
Included in Regulatory Assets/Liabilities | (9) | [2] | (11) | [2] | (81) | [2] | (12) | [2] | ||||||||
Purchases, (Sales) | 0 | 0 | 0 | 0 | ||||||||||||
Issuances (Settlements) | 0 | [3] | 0 | [3] | 0 | [3] | 0 | [3] | ||||||||
Transfers In (Out) | 0 | [4] | 0 | [4] | 0 | [4] | 0 | [4] | ||||||||
Closing Balance | $ 13 | $ (52) | $ 13 | $ (52) | ||||||||||||
|